Trevi Therapeutics Has Priced An Underwritten Offering Of 12.5M Shares At $4.00 Per Share, For Total Proceeds Of $50M
Trevi Therapeutics Has Priced An Underwritten Offering Of 12.5M Shares At $4.00 Per Share, For Total Proceeds Of $50M
Trevi Therapeutics 已以每股 4.00 美元的價格定價 1250萬股的承銷發行,預計總收入爲 5000 萬美元。
Trevi Therapeutics Has Priced An Underwritten Offering Of 12.5M Shares At $4.00 Per Share, For Total Proceeds Of $50M
Trevi Therapeutics 已以每股 4.00 美元的價格定價 1250萬股的承銷發行,預計總收入爲 5000 萬美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。